These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 10586392)

  • 1. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.
    Piotrovsky V
    AAPS J; 2005 Oct; 7(3):E609-24. PubMed ID: 16353940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ketoconazole on azimilide pharmacokinetics in healthy subjects.
    El Mouelhi M; Worley DJ; Kuzmak B; Destefano AJ; Thompson GA
    Br J Clin Pharmacol; 2004 Dec; 58(6):641-7. PubMed ID: 15563362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azimilide pharmacokinetics and pharmacodynamics upon multiple oral dosing.
    Corey A; Al-Khalidi H; Brezovic C; Marcello S; Parekh N; Taylor K; Karam R
    Biopharm Drug Dispos; 1999 Mar; 20(2):59-68. PubMed ID: 10206320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age and gender on azimilide pharmacokinetics after a single oral dose of azimilide dihydrochloride.
    Corey A; Agnew J; Bao J; Bryson P; Comer P; Griffith S; Li J
    J Clin Pharmacol; 1997 Oct; 37(10):946-53. PubMed ID: 9505986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulation.
    Corey AE; Agnew JR; Valentine SN; Nesbitt JD; Wagner DL; Powell JH; Thompson GA
    J Clin Pharmacol; 1999 Dec; 39(12):1272-6. PubMed ID: 10586393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous azimilide on cardiac performance, fibrillation threshold, and hemodynamics in anesthetized dogs.
    Brooks RR; Finch SL
    Arzneimittelforschung; 2000 Jul; 50(7):597-605. PubMed ID: 10965415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of azimilide on CYP2C19-mediated metabolism.
    El Mouelhi M; Worley DJ; Kuzmak B; Destefano AJ; Thompson GA
    J Clin Pharmacol; 2004 Apr; 44(4):373-8. PubMed ID: 15051744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics following intravenous doses of azimilide dihydrochloride.
    Corey A; Agnew J; Brum J; Parekh N; Valentine S; Williams M
    J Clin Pharmacol; 1999 Dec; 39(12):1263-71. PubMed ID: 10586392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azimilide dihydrochloride, a novel antiarrhythmic agent.
    Karam R; Marcello S; Brooks RR; Corey AE; Moore A
    Am J Cardiol; 1998 Mar; 81(6A):40D-46D. PubMed ID: 9537222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azimilide dihydrochloride: a unique class III antiarrhythmic agent.
    Tran HT
    Heart Dis; 1999; 1(2):114-6. PubMed ID: 11720612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azimilide for atrial fibrillation: clinical trial results and implications.
    Pritchett EL; Marcello SR
    Card Electrophysiol Rev; 2003 Sep; 7(3):215-9. PubMed ID: 14739716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azimilide dihydrochloride: a new class III anti-arrhythmic agent.
    Abrol R; Page RL
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2705-15. PubMed ID: 11060832
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.